Cancer Drug Shortages Continue With No Immediate Path Toward Relief

All responding members of the National Comprehensive Cancer Network (NCCN) reported ongoing shortages of commonly used generic chemotherapy drugs, with ifosfamide identified as the most critically affected agent. The annual survey underscores a systemic supply-chain crisis that forces oncologists to substitute preferred regimens, potentially compromising treatment outcomes. No immediate policy or manufacturing solution is on the horizon, raising concern across U.S. cancer centers.